Protokinetix Company Insiders
| PKTX Stock | USD 0.01 0.0007 6.80% |
Protokinetix employs about 7 people. The company is managed by 3 executives with a total tenure of roughly 10 years, averaging almost 3.0 years of service per executive, having 2.33 employees per reported executive. Break down of Protokinetix's management performance can provide insight into the company performance.
| Clarence Smith Chairman Chairman, CEO and Pres |
Protokinetix |
Protokinetix Management Team Effectiveness
The company has return on total asset (ROA) of (2.224) % which means that it has lost $2.224 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.0255) %, meaning that it created substantial loss on money invested by shareholders. Protokinetix's management efficiency ratios could be used to measure how well Protokinetix manages its routine affairs as well as how well it operates its assets and liabilities.Protokinetix Workforce Comparison
Protokinetix is considered to be number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 30.0. Protokinetix totals roughly 7.0 in number of employees claiming about 23% of stocks in Biotechnology industry.
Protokinetix Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Protokinetix Price Series Summation is a cross summation of Protokinetix price series and its benchmark/peer.
Protokinetix Notable Stakeholders
A Protokinetix stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Protokinetix often face trade-offs trying to please all of them. Protokinetix's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Protokinetix's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Clarence Smith | Chairman, CEO and Pres | Profile | |
| JeanCharles Quirion | Head Rouen | Profile | |
| Michael CPA | Chief Officer | Profile |
About Protokinetix Management Performance
The success or failure of an entity such as Protokinetix often depends on how effective the management is. Protokinetix management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Protokinetix management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Protokinetix management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins or anti-aging glycoproteins . ProtoKinetix, Incorporated was incorporated in 1999 and is based in Marietta, Ohio. Protokinetix is traded on OTC Exchange in the United States.
Please note, the imprecision that can be found in Protokinetix's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Protokinetix. Check Protokinetix's Beneish M Score to see the likelihood of Protokinetix's management manipulating its earnings.
Protokinetix Workforce Analysis
Traditionally, organizations such as Protokinetix use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Protokinetix within its industry.Protokinetix Manpower Efficiency
Return on Protokinetix Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 332.8K | |
| Net Loss Per Executive | 776.4K | |
| Working Capital Per Employee | 20K | |
| Working Capital Per Executive | 46.7K |
Additional Tools for Protokinetix Pink Sheet Analysis
When running Protokinetix's price analysis, check to measure Protokinetix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protokinetix is operating at the current time. Most of Protokinetix's value examination focuses on studying past and present price action to predict the probability of Protokinetix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protokinetix's price. Additionally, you may evaluate how the addition of Protokinetix to your portfolios can decrease your overall portfolio volatility.